These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 15638783)

  • 41. Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
    Monroe VS; Kerensky RA; Rivera E; Smith KM; Pepine CJ
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):23S-30S. PubMed ID: 12644337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration.
    Huang H; Koelle P; Fendler M; Schröttle A; Czihal M; Hoffmann U; Conrad M; Kuhlencordt PJ
    Atherosclerosis; 2014 Jul; 235(1):213-22. PubMed ID: 24858340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in transcriptome of macrophages in atherosclerosis.
    Chistiakov DA; Bobryshev YV; Orekhov AN
    J Cell Mol Med; 2015 Jun; 19(6):1163-73. PubMed ID: 25973901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice.
    Jung IH; Choi JH; Jin J; Jeong SJ; Jeon S; Lim C; Lee MR; Yoo JY; Sonn SK; Kim YH; Choi BK; Kwon BS; Seoh JY; Lee CW; Kim DY; Oh GT
    FASEB J; 2014 Nov; 28(11):4779-91. PubMed ID: 25059229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophages and atherosclerotic plaque stability.
    Libby P; Geng YJ; Aikawa M; Schoenbeck U; Mach F; Clinton SK; Sukhova GK; Lee RT
    Curr Opin Lipidol; 1996 Oct; 7(5):330-5. PubMed ID: 8937525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
    Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
    Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomarkers of atherosclerotic plaque instability and rupture.
    Koenig W; Khuseyinova N
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):15-26. PubMed ID: 17082488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteolysis of the pericellular matrix: a novel element determining cell survival and death in the pathogenesis of plaque erosion and rupture.
    Lindstedt KA; Leskinen MJ; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1350-8. PubMed ID: 15191939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability.
    Johnson JL; Jenkins NP; Huang WC; Di Gregoli K; Sala-Newby GB; Scholtes VP; Moll FL; Pasterkamp G; Newby AC
    Mediators Inflamm; 2014; 2014():276457. PubMed ID: 25301980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immune factors in atherosclerosis].
    Pasqui AL; Bova G; Maffei S; Auteri A
    Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of apoptosis in atherosclerosis and its therapeutic implications.
    Stoneman VE; Bennett MR
    Clin Sci (Lond); 2004 Oct; 107(4):343-54. PubMed ID: 15230690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metalloproteinase production from macrophages - a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction.
    Newby AC
    Exp Physiol; 2016 Nov; 101(11):1327-1337. PubMed ID: 26969796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
    Tiwari RL; Singh V; Barthwal MK
    Med Res Rev; 2008 Jul; 28(4):483-544. PubMed ID: 18000963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.